UBS Lux Equity Fund Biotech USD vs Allianz US High Yield AM

UBS Lux Equity Fund Biotech USD vs Allianz US High Yield AM

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

2. Allianz US High Yield AM

  • Security

    Allianz US High Yield AM USD

  • Fee

    1.24%

  • ISIN

    LU0516397667

  • Holdings

    3

Fund Holdings

We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.9) and Moderna (9.21). In comparison with Allianz US High Yield AM, we have 3 holdings where CCF Holdings is the largest holding (2.69), followed by Iron Mountain (2.22) and CCO Holdings LLC (2.2).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Allianz US High Yield AM.

UBS Lux Equity Fund Biotech USD Allianz US High Yield AM
1. Regeneron Pharmaceuticals Inc
10.04 %
1. CCF Holdings LLC
USA
2.69 %
2. Vertex Pharmaceuticals Inc
9.9 %
2. Iron Mountain Inc
USA
2.22 %
3. Moderna Inc
9.21 %
3. CCO Holdings LLC
USA
2.2 %
4. Alnylam Pharmaceuticals Inc
6.54 %
-
5. AbbVie Inc
USA
5.52 %
-
6. Gilead Sciences Inc
USA
4.66 %
-
7. Amgen Inc
4.32 %
-
8. BioNTech SE
4.13 %
-
9. Karuna Therapeutics Inc
3.75 %
-
10. Royalty Pharma Plc
3.28 %
-

The list of fund holdings was last updated on April 17, 2025.